Related Experiment Videos
Acute pancreatitis.
Anil B Nagar1, Fred S Gorelick
1Internal Medicine and Gastroenterology, West Haven VA and Yale University, West Haven, Connecticut 06516, USA. anil.nagar@yale.edu
Current Opinion in Gastroenterology
|February 4, 2005
Summary
Acute pancreatitis involves early cellular activation and inflammation. Research shows potential therapeutic targets, including pancreatic duct stenting, to manage this severe condition.
Area of Science:
- Gastroenterology
- Cellular Biology
- Inflammation Research
Background:
- Acute pancreatitis presents significant morbidity and mortality.
- Understanding early cellular events and inflammatory pathways is crucial for effective management.
Purpose of the Study:
- To review recent advancements in understanding and managing acute pancreatitis.
- To highlight novel therapeutic targets and diagnostic methods.
Main Methods:
- Literature review of relevant articles published within the past year.
- Analysis of experimental and clinical findings related to acute pancreatitis.
Main Results:
- Early events include digestive zymogen activation and nuclear factor kappaB (NF-κB) pathway involvement.
- Inhibitors like curcumin and chloroquine show promise in experimental models.
- Sensory neurons, cyclo-oxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and CC chemokine receptor antagonists demonstrate potential in attenuating inflammation.
- Magnetic resonance imaging (MRI) is effective for staging disease severity.
- Pancreatic duct stenting reduces post-ERCP pancreatitis risk.
Conclusions:
- Early acinar cell events and inflammatory regulation are key areas of ongoing research.
- While experimental treatments show promise, clinical efficacy for many inhibitors is yet to be proven.
- Compartmentalization of inflammation may guide future therapeutic strategies.
- Pancreatic duct stenting is a validated intervention for preventing post-ERCP pancreatitis in high-risk individuals.